Boston Microfluidics

Website http://www.bostonmicrofluidics.com

Founded 2017

Follow

Overview

Boston Microfluidics has developed easy to use devices that enable a wide range of test to be done at home. BMF seeks to expand the home market, which is currently dominated by pregnancy and glucose testing, to include STD and food allergy testing. This will allow individuals quick answers and anxiety relief with out needing a doctors appointment. Our initial customers will be Americans in their teens through their 40s.

Management Team

CEO

Brandon Johnson

Mr. Johnson has been leading BMF since it's inception. He has raised millions of dollars in difficult markets and over seen the development of multiple products including the testing platform. Mr. Johnson's background is in biomedical engineering and healthcare diagnostics.

Roger Dowd

Roger was CEO of Biotrofix where he doubled revenues in one year. Before that he was CEO of Decision Biomarkers where he built and lead a 40 person team in the development of a multiplex immunoassay instrument. Prior to that Roger was General Manager of GSI Lumonics which sold to Packard Bioscience for $120M. Roger is currently on the board of directors of Firefly Bioworks.

Catherine Fink Ph.D.

Catherine was the VP of Operations at Corgenix where she oversaw the development and FDA clearance of 50 assays. Prior to her time at Corgenix she oversaw the development of the first HIV test designed for use outside the lab.